These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 30753103)
1. Assessment of risk factors, cost of treatment, and therapy outcome in stroke patients: evidence from cross-sectional study. Chhabra M; Sharma A; Ajay KR; Rathore MS Expert Rev Pharmacoecon Outcomes Res; 2019 Oct; 19(5):575-580. PubMed ID: 30753103 [No Abstract] [Full Text] [Related]
2. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Brüggenjürgen B; Rossnagel K; Roll S; Andersson FL; Selim D; Müller-Nordhorn J; Nolte CH; Jungehülsing GJ; Villringer A; Willich SN Value Health; 2007; 10(2):137-43. PubMed ID: 17391422 [TBL] [Abstract][Full Text] [Related]
3. Costs of acute care of first-ever ischemic stroke in Taiwan. Chang KC; Tseng MC Stroke; 2003 Nov; 34(11):e219-21. PubMed ID: 14551400 [TBL] [Abstract][Full Text] [Related]
5. Resource utilization and costs for treatment of stroke patients in an acute stroke unit in Greece. Kritikou P; Spengos K; Zakopoulos N; Tountas Y; Yfantopoulos J; Vemmos K Clin Neurol Neurosurg; 2016 Mar; 142():8-14. PubMed ID: 26795492 [TBL] [Abstract][Full Text] [Related]
6. Impact of transfer status on hospitalization cost and discharge disposition for acute ischemic stroke across the US. Sonig A; Lin N; Krishna C; Natarajan SK; Mokin M; Hopkins LN; Snyder KV; Levy EI; Siddiqui AH J Neurosurg; 2016 May; 124(5):1228-37. PubMed ID: 26452123 [TBL] [Abstract][Full Text] [Related]
7. High-Resolution Pulse Oximetry (HRPO): A Cost-Effective Tool in Screening for Obstructive Sleep Apnea (OSA) in Acute Stroke and Predicting Outcome. Yaddanapudi SS; Pineda MC; Boorman DW; Bryne RE; Hing KL; Sharma S J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2986-2992. PubMed ID: 30097400 [TBL] [Abstract][Full Text] [Related]
8. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]
9. Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke. Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Papadopoulou M; Kostaki S; Dourliou V; Papagianni M; Savopoulos C; Hatzitolios AI Am J Hypertens; 2015 Jun; 28(6):765-71. PubMed ID: 25468807 [TBL] [Abstract][Full Text] [Related]
10. Effects of Stroke Unit Care in Acute Ischemic Stroke Patient Ineligible for Thrombolytic Treatment. Rajborirug K; Tumviriyakul H; Suwanno J J Med Assoc Thai; 2017 Apr; 100(4):410-7. PubMed ID: 29911837 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the cost of stroke management in Dakar, Senegal]. Touré K; Ndiaye NM; Sène Diouf F; Ndiaye M; Diallo AK; Ndao AK; Thiam A; Diagne M; Diop AG; Ndiaye MN; Ndiaye IP Med Trop (Mars); 2005 Nov; 65(5):458-64. PubMed ID: 16465816 [TBL] [Abstract][Full Text] [Related]
12. Cost of post-stroke outpatient care in Malaysia. Akhavan Hejazi SM; Mazlan M; Abdullah SJ; Engkasan JP Singapore Med J; 2015 Feb; 56(2):116-9. PubMed ID: 25715857 [TBL] [Abstract][Full Text] [Related]
13. Cost and Outcome in Pediatric Ischemic Stroke. Hamilton W; Huang H; Seiber E; Lo W J Child Neurol; 2015 Oct; 30(11):1483-8. PubMed ID: 25660132 [TBL] [Abstract][Full Text] [Related]
14. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Diringer MN; Edwards DF; Mattson DT; Akins PT; Sheedy CW; Hsu CY; Dromerick AW Stroke; 1999 Apr; 30(4):724-8. PubMed ID: 10187869 [TBL] [Abstract][Full Text] [Related]
15. Outcomes after acute ischemic stroke in the United States: does residential ZIP code matter? Agarwal S; Menon V; Jaber WA J Am Heart Assoc; 2015 Mar; 4(3):e001629. PubMed ID: 25773298 [TBL] [Abstract][Full Text] [Related]
16. Stroke in Switzerland: social determinants of treatment access and cost of illness. Snozzi P; Blank PR; Szucs TD J Stroke Cerebrovasc Dis; 2014; 23(5):926-32. PubMed ID: 24119621 [TBL] [Abstract][Full Text] [Related]
17. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Houle SK; Chuck AW; McAlister FA; Tsuyuki RT Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863 [TBL] [Abstract][Full Text] [Related]
18. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France. Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623 [TBL] [Abstract][Full Text] [Related]
19. Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital: Evidence from a Cross-Sectional Study. Ahlawat R; Tiwari P; D'Cruz S Value Health Reg Issues; 2017 May; 12():36-40. PubMed ID: 28648314 [TBL] [Abstract][Full Text] [Related]
20. An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands. Boersma C; Carides GW; Atthobari J; Voors AA; Postma MJ Clin Ther; 2007 May; 29(5):963-971. PubMed ID: 17697915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]